Physician profile
Lauren Gore
NPI 1629282702
$496.68
in general payments reported to CMS, 2019-2025
8 companies · $85.11 in 2025
The $85.11 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.21 · 2022: $20.93 · 2023: $123 · 2024: $250 · 2025: $85.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $457.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $251.68 | 2024-2025 | |
| Corium, LLC | $90.77 | 2023-2024 | Azstarys |
| Pfizer INC. | $52.76 | 2022-2023 | |
| Kestra Medical Technology Services, INC. | $42.22 | 2025 | Assure Wcd |
| Boston Scientific Corporation | $18.21 | 2021 | |
| Merck Sharp & Dohme LLC | $14.74 | 2025 | Vaqta, Gardasil 9, Vaxneuvance |
| Supernus Pharmaceuticals, INC. | $13.31 | 2023 | Qelbree |
| Seqirus USA INC | $12.99 | 2023 | Flucelvax Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Gore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.